ResearcherFudan UniversityNo recent work listed
Ding-Fang Cai
Matched on ORCID iD 0000-0001-6297-8205; OpenAlex author ID A5101790317. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 2
- Retraction Note: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-023-48852-5↗
- MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/srep22793↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chenye Shi · 2 shared papers, 2016–2023 · strength 0.29
- Paper Retraction Note: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal… DOI 10.1038/s41598-023-48852-5↗
- Paper MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. DOI 10.1038/srep22793↗
- Wei Wei · 2 shared papers, 2016–2023 · strength 0.29
- Paper Retraction Note: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal… DOI 10.1038/s41598-023-48852-5↗
- Paper MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. DOI 10.1038/srep22793↗
- Dansong Wang · 2 shared papers, 2016–2023 · strength 0.29
- Paper Retraction Note: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal… DOI 10.1038/s41598-023-48852-5↗
- Paper MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma. DOI 10.1038/srep22793↗
- Yue Fan · 1 shared paper, 2023 · strength 0.22
- Yue Fan · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.